Priovant
Lisa Dyer is Senior Manager, Clinical Operations at Priovant Therapeutics. Lisa brings more than 18 years of experience in ophthalmology and clinical research. She has worked closely with sites, sponsors, and CROs in Phase II-IV clinical drug and device studies across multiple therapeutic areas, including ophthalmology, infectious disease, autoimmune disease, oncology, and vaccines. Lisa holds a BS in Health Science from ECPI University and an MS in Clinical Operations and Healthcare Management from George Washington University.
This person is not in any offices
Priovant
2 followers
Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the heaviest patient burdens.